Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Parathyroid Hormone | 5 | 2008 | 25 | 0.340 |
Why?
|
| Parathyroidectomy | 4 | 2008 | 12 | 0.290 |
Why?
|
| Hyperparathyroidism | 4 | 2004 | 7 | 0.250 |
Why?
|
| Famotidine | 1 | 2001 | 2 | 0.220 |
Why?
|
| Histamine H2 Antagonists | 1 | 2001 | 8 | 0.220 |
Why?
|
| Autistic Disorder | 1 | 2001 | 42 | 0.210 |
Why?
|
| Laboratories | 2 | 1989 | 28 | 0.200 |
Why?
|
| Medical Laboratory Science | 2 | 1989 | 12 | 0.190 |
Why?
|
| Monitoring, Intraoperative | 3 | 2008 | 43 | 0.120 |
Why?
|
| Graft Survival | 2 | 2008 | 111 | 0.110 |
Why?
|
| Brain | 1 | 2001 | 1655 | 0.110 |
Why?
|
| Clinical Laboratory Information Systems | 1 | 1989 | 2 | 0.100 |
Why?
|
| Information Systems | 1 | 1989 | 18 | 0.100 |
Why?
|
| Robotics | 1 | 1989 | 17 | 0.100 |
Why?
|
| Equipment and Supplies, Hospital | 1 | 1988 | 1 | 0.100 |
Why?
|
| Laboratories, Hospital | 1 | 1988 | 3 | 0.090 |
Why?
|
| Blood Specimen Collection | 1 | 2008 | 14 | 0.090 |
Why?
|
| Hyperparathyroidism, Primary | 1 | 2008 | 6 | 0.090 |
Why?
|
| Transplantation Tolerance | 1 | 2008 | 4 | 0.090 |
Why?
|
| Gelatinases | 1 | 2008 | 4 | 0.090 |
Why?
|
| Chemotaxis | 1 | 2008 | 6 | 0.090 |
Why?
|
| Skin Transplantation | 1 | 2008 | 17 | 0.090 |
Why?
|
| Heart Transplantation | 1 | 2008 | 50 | 0.090 |
Why?
|
| Physicians' Offices | 1 | 1987 | 7 | 0.090 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2008 | 56 | 0.090 |
Why?
|
| Health Facilities | 1 | 1987 | 11 | 0.090 |
Why?
|
| Graft Rejection | 1 | 2008 | 84 | 0.090 |
Why?
|
| ADAM Proteins | 1 | 2008 | 95 | 0.090 |
Why?
|
| Clinical Laboratory Techniques | 1 | 1987 | 38 | 0.080 |
Why?
|
| T-Lymphocytes | 1 | 2008 | 242 | 0.080 |
Why?
|
| CD8-Positive T-Lymphocytes | 1 | 2008 | 179 | 0.080 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2008 | 225 | 0.080 |
Why?
|
| Parathyroid Glands | 1 | 2004 | 9 | 0.070 |
Why?
|
| Calcium | 3 | 2003 | 519 | 0.070 |
Why?
|
| Body Weight | 2 | 2001 | 167 | 0.060 |
Why?
|
| Child | 4 | 2003 | 1572 | 0.060 |
Why?
|
| Receptors, Histamine H2 | 1 | 2001 | 1 | 0.060 |
Why?
|
| Histamine | 1 | 2001 | 9 | 0.060 |
Why?
|
| Male | 10 | 2008 | 17583 | 0.050 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2001 | 512 | 0.050 |
Why?
|
| Double-Blind Method | 1 | 2001 | 559 | 0.050 |
Why?
|
| Immunoenzyme Techniques | 1 | 1999 | 54 | 0.050 |
Why?
|
| Pilot Projects | 1 | 2001 | 455 | 0.050 |
Why?
|
| Troponin I | 1 | 1999 | 21 | 0.050 |
Why?
|
| Research Design | 1 | 2001 | 238 | 0.050 |
Why?
|
| Treatment Outcome | 3 | 2008 | 3910 | 0.050 |
Why?
|
| Child, Preschool | 1 | 2001 | 786 | 0.050 |
Why?
|
| Myocardial Infarction | 1 | 1999 | 187 | 0.040 |
Why?
|
| United States | 3 | 1989 | 2539 | 0.040 |
Why?
|
| Creatine Kinase | 1 | 1977 | 36 | 0.040 |
Why?
|
| Cytokines | 2 | 2008 | 364 | 0.040 |
Why?
|
| Humans | 11 | 2008 | 31481 | 0.040 |
Why?
|
| Evaluation Studies as Topic | 2 | 2008 | 60 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2008 | 580 | 0.030 |
Why?
|
| Mice | 2 | 2008 | 1894 | 0.030 |
Why?
|
| Middle Aged | 6 | 2008 | 11209 | 0.030 |
Why?
|
| Adult | 6 | 2008 | 9779 | 0.030 |
Why?
|
| Antipyrine | 1 | 1991 | 1 | 0.030 |
Why?
|
| Sexual Maturation | 1 | 1991 | 3 | 0.030 |
Why?
|
| Testosterone | 1 | 1991 | 36 | 0.030 |
Why?
|
| Estradiol | 1 | 1991 | 68 | 0.030 |
Why?
|
| Saliva | 1 | 1991 | 62 | 0.030 |
Why?
|
| Prospective Studies | 2 | 2008 | 1934 | 0.030 |
Why?
|
| Female | 7 | 2008 | 18253 | 0.030 |
Why?
|
| Autoanalysis | 1 | 1989 | 3 | 0.030 |
Why?
|
| Adolescent | 4 | 2003 | 2667 | 0.020 |
Why?
|
| Aged | 4 | 2008 | 10295 | 0.020 |
Why?
|
| Probability | 1 | 2008 | 104 | 0.020 |
Why?
|
| Dipeptides | 1 | 2008 | 7 | 0.020 |
Why?
|
| Mice, Inbred C3H | 1 | 2008 | 35 | 0.020 |
Why?
|
| Mice, Inbred Strains | 1 | 2008 | 36 | 0.020 |
Why?
|
| Reproducibility of Results | 2 | 2003 | 886 | 0.020 |
Why?
|
| Chemokines | 1 | 2008 | 31 | 0.020 |
Why?
|
| Doxycycline | 1 | 2008 | 23 | 0.020 |
Why?
|
| Protease Inhibitors | 1 | 2008 | 21 | 0.020 |
Why?
|
| Leukocytes, Mononuclear | 1 | 2008 | 91 | 0.020 |
Why?
|
| Collagen | 1 | 2008 | 111 | 0.020 |
Why?
|
| Animals | 2 | 2008 | 5312 | 0.020 |
Why?
|
| Chemistry Techniques, Analytical | 1 | 1987 | 1 | 0.020 |
Why?
|
| Hematologic Tests | 1 | 1987 | 6 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 296 | 0.020 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2008 | 59 | 0.020 |
Why?
|
| Skin | 1 | 2008 | 136 | 0.020 |
Why?
|
| Aged, 80 and over | 3 | 2003 | 5234 | 0.020 |
Why?
|
| Equipment Design | 1 | 1987 | 198 | 0.020 |
Why?
|
| Decision Making | 1 | 1988 | 232 | 0.020 |
Why?
|
| Mice, Inbred C57BL | 1 | 2008 | 548 | 0.020 |
Why?
|
| Hyperplasia | 1 | 2004 | 26 | 0.020 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2008 | 300 | 0.020 |
Why?
|
| Intraoperative Care | 1 | 2003 | 58 | 0.020 |
Why?
|
| Patient Selection | 1 | 2004 | 264 | 0.020 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 2028 | 0.020 |
Why?
|
| Immunoradiometric Assay | 1 | 2001 | 3 | 0.010 |
Why?
|
| Parathyroid Neoplasms | 1 | 2001 | 5 | 0.010 |
Why?
|
| Intraoperative Period | 1 | 2001 | 39 | 0.010 |
Why?
|
| Frozen Sections | 1 | 2001 | 11 | 0.010 |
Why?
|
| Predictive Value of Tests | 1 | 2003 | 637 | 0.010 |
Why?
|
| Isoenzymes | 2 | 1980 | 63 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1980 | 3 | 0.010 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 1980 | 9 | 0.010 |
Why?
|
| Adenoma | 1 | 2001 | 63 | 0.010 |
Why?
|
| Muscles | 1 | 1980 | 77 | 0.010 |
Why?
|
| Postoperative Period | 1 | 2000 | 295 | 0.010 |
Why?
|
| ROC Curve | 1 | 1999 | 153 | 0.010 |
Why?
|
| Aqueous Humor | 1 | 1978 | 1 | 0.010 |
Why?
|
| Retinoblastoma | 1 | 1978 | 1 | 0.010 |
Why?
|
| Eye Neoplasms | 1 | 1978 | 5 | 0.010 |
Why?
|
| Catecholamines | 1 | 1978 | 17 | 0.010 |
Why?
|
| Reoperation | 1 | 2001 | 938 | 0.010 |
Why?
|
| Brain Injuries | 1 | 1977 | 58 | 0.010 |
Why?
|
| Body Surface Area | 1 | 1991 | 3 | 0.010 |
Why?
|
| Metabolic Clearance Rate | 1 | 1991 | 9 | 0.010 |
Why?
|
| Puberty | 1 | 1991 | 10 | 0.010 |
Why?
|
| Age Factors | 1 | 1991 | 943 | 0.010 |
Why?
|
| Time Factors | 1 | 1991 | 1902 | 0.000 |
Why?
|
| Metanephrine | 1 | 1978 | 1 | 0.000 |
Why?
|
| Methoxyhydroxyphenylglycol | 1 | 1978 | 1 | 0.000 |
Why?
|
| Normetanephrine | 1 | 1978 | 1 | 0.000 |
Why?
|
| Vanilmandelic Acid | 1 | 1978 | 1 | 0.000 |
Why?
|